Nothing Special   »   [go: up one dir, main page]

SU303886A1 - METHOD OF OBTAINING A LIVING GRIPPOSOUS VACCINE - Google Patents

METHOD OF OBTAINING A LIVING GRIPPOSOUS VACCINE

Info

Publication number
SU303886A1
SU303886A1 SU1357184A SU1357184A SU303886A1 SU 303886 A1 SU303886 A1 SU 303886A1 SU 1357184 A SU1357184 A SU 1357184A SU 1357184 A SU1357184 A SU 1357184A SU 303886 A1 SU303886 A1 SU 303886A1
Authority
SU
USSR - Soviet Union
Prior art keywords
vaccine
obtaining
gripposous
living
virus
Prior art date
Application number
SU1357184A
Other languages
Russian (ru)
Inventor
Л. А. Яковлева А. Н. Александрова А. Алексеева
Original Assignee
Московский научно исследовательский институт вирусных препаратов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Московский научно исследовательский институт вирусных препаратов filed Critical Московский научно исследовательский институт вирусных препаратов
Priority to SU1357184A priority Critical patent/SU303886A1/en
Application granted granted Critical
Publication of SU303886A1 publication Critical patent/SU303886A1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Description

Изобретение относитс  к области медицины, точнее к методам получени  профилактических вакцин, и касаетс  способов получени  живой гриппозной вакцины.The invention relates to the field of medicine, more specifically to methods for producing prophylactic vaccines, and relates to methods for producing a live influenza vaccine.

Известный способ нолучеии  живой гриппозной вакцины, основанный на приготовлении вируссодержащей суспензии путем внесени  в среду культивировани , в качестве которой используетс  аллантоисна  жидкость 9-10-дневных куриных эмбрионов, вирусов А2 и В, сравнительно сложен.The known method of obtaining live influenza vaccine, based on the preparation of a virus-containing suspension by introducing it into a culture medium, which uses allantoic liquid of 9-10 days old chicken embryos, A2 and B viruses, is relatively complex.

Цель насто щего изобретени  - упроп1,епие процесса получени  живой гриппозной вакцины-достигаетс  приготовлением вируссодержащей суспепзии из тканевой культуры почек 19-дневных куриных эмбрионов.The purpose of the present invention is to support the process of obtaining a live flu vaccine, which is achieved by preparing a virus-containing suspension from kidney tissue culture of 19-day-old chicken embryos.

Дл  нолучени  живой гриппозпой вакцины по предлагаемому способу извлеченные почки 19-дневных куриных эмбрионов измельчают, например обрабатыва  трипсином или механическим способом, полученную взвесь перенос т в питательную среду, куда одновременно внос т вирусы гриппа типа А и В в колнчестве 10«-10 и ИДбо па 1 л со ответственно.In order to obtain a live influenza vaccine using the proposed method, the extracted kidneys of 19-day-old chicken embryos are crushed, for example, treated with trypsin or mechanically, the resulting suspension is transferred to a nutrient medium, where viruses of type A and B are simultaneously administered in 10 -10 and ID Pa 1 l accordingly.

Средо дл  культивировани   вл етс  синтетическа  среда 199 с мономипииом (100 ед/мл) п нистатином (15 ед/мл). Дл  вируса гриппа тнпа В в среду дополнительно ввод т 2-5% нрогретой сыворотки крупного рогатого скота.The culture medium is synthetic medium 199 with monomipium (100 U / ml) p nystatin (15 U / ml). For influenza A virus, an additional 2–5% of heated cattle serum is added to the medium.

Культивирование ведут при перемешнван1П1 и температуре 37°С в течение 48-72 час дл  вируса гриппа тппа АЗ и 96-120 час дл  вируса гриппа типа В.Cultivation is carried out at vmeshnivan1P1 and a temperature of 37 ° C for 48-72 hours for influenza virus TPA AZ and 96-120 hours for influenza virus type B.

Предмет изобретени Subject invention

Способ получепи  живой гриппозной вакципы , основанный на прпготовлении вируссодержащей суспензии путем внесени  в среду культивировани  вируса гриппа штамма Ач и В, отличающийс  тем, что, с целью упрощепн  процесса, вируссодержащую суспепзию готов т из тканевой культуры почек 19-дневных куриных эмбрионов.The method of obtaining live influenza vaccine, based on the preparation of a virus-containing suspension by introducing the Ah and B strain into the influenza virus cultivation medium, characterized in that, in order to simplify the process, the virus-containing suspension is prepared from tissue culture of the kidneys of 19-day-old chicken embryos.

SU1357184A 1969-08-15 1969-08-15 METHOD OF OBTAINING A LIVING GRIPPOSOUS VACCINE SU303886A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU1357184A SU303886A1 (en) 1969-08-15 1969-08-15 METHOD OF OBTAINING A LIVING GRIPPOSOUS VACCINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU1357184A SU303886A1 (en) 1969-08-15 1969-08-15 METHOD OF OBTAINING A LIVING GRIPPOSOUS VACCINE

Publications (1)

Publication Number Publication Date
SU303886A1 true SU303886A1 (en) 1973-10-19

Family

ID=20447117

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1357184A SU303886A1 (en) 1969-08-15 1969-08-15 METHOD OF OBTAINING A LIVING GRIPPOSOUS VACCINE

Country Status (1)

Country Link
SU (1) SU303886A1 (en)

Similar Documents

Publication Publication Date Title
US6048537A (en) Method for preparing an influenza virus, antigens obtained and applications thereof
JPH0278634A (en) Production of ibdv in continuous cell line
CN102617731B (en) Porcine circovirus-resistant type 2 egg yolk antibody and preparation method and application thereof
CN102178945A (en) Preparation method of inactivated vaccine for iridovirus of grouper
SU303886A1 (en) METHOD OF OBTAINING A LIVING GRIPPOSOUS VACCINE
CN1059471A (en) Heamophilus paragallinarum vaccine
US4169761A (en) Process for the cultivation of viruses
CN104725503A (en) Fugu rubripes nervous necrosis virus capsid protein egg yolk antibody and application thereof
Takemoto et al. Influence of acid polysaccharides on plaque formation by influenza A2 and B viruses
SU490824A1 (en) Method of inactivating infectiousness of viruses
Musser et al. Measles virus growth in canine renal cell cultures
Findlay A note on the cultivation of the virus of fowl-pox
CN102965344A (en) Production of infectious bronchitis virus and vaccine from cell line
RU2143921C1 (en) Vaccine against foot and mouth of type a and method of its preparing
RU2212895C2 (en) Vaccine against o-type foot-and-mouth disease and method for its preparing
US3420934A (en) Sprayable or subcutaneously administrable vaccine for the immunization of mustelines against distemper and process for its preparation
CN108261543B (en) The preparation method and applications of subculture cell source ND, IB, AI triple inactivated vaccine
GB930451A (en) Process for propagating rabies virus
RU2220744C1 (en) Vaccine against foot-and-mouth asia-1 type and method for it preparing
RU2538617C2 (en) Method of production of antirabic vaccine
FR2261779A1 (en) Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium
RU2080125C1 (en) Method of preparing vaccine against rabies and carnivorous plague
US3629396A (en) Avian encephalomyelitis vaccine
RU2134590C1 (en) Method of preparing inactivated vaccine against rabies in animals
SU1317021A1 (en) Manъs embryo skin and muscle diploid cells strain used for cultivating viruses